Prerpints.org logo
Preprint
Article

This version is not peer-reviewed.

Patient Knowledge, Medication Adherence, and Influencing Factors: A Cross-Sectional Study among Hypertensive Patients in Greece

A peer-reviewed version of this preprint was published in:
Healthcare 2024, 12(9), 916. https://doi.org/10.3390/healthcare12090916

Submitted:

19 March 2024

Posted:

20 March 2024

You are already at the latest version

Abstract
This study aimed to investigate the knowledge of patients with hypertension about their condition, adherence to antihypertensive medication, and the factors influencing it. A cross-sectional study was conducted in two cardiology outpatient clinics of two tertiary hospitals, in Greece. The study included 188 patients diagnosed with hypertension. The patient’s knowledge about their disease and adherence to medication were assessed by using the HK-LS and A-14 scales, respectively. Patients had sufficient knowledge levels about their disease, but significantly low levels of adherence to medication. Patients with higher knowledge levels were more adherent to medications [r(188) = 0.885, p < 0.001]. By using multivariate analysis, higher age (p = 0.018), residence in a more populous area (p = 0.041), more years with the disease (p = 0.012), and a lower number of medications (p = 0.03) were associated with higher levels of knowledge. Conversely, younger age (p = 0.036), lower educational levels (p = 0.048), fewer years with the disease (p = 0.001), and a higher number of medications (p = 0.003) were associated with lower adherence to medication. The Greek patients' hypertension knowledge was sufficient, however, adherence to medication was significantly low. Healthcare managers could utilize our findings to design targeted interventions for improving adherence to medication for these patients.
Keywords: 
Patient Knowledge
;  
Medication Adherence
;  
Hypertensive Patients
Subject: 
Public Health and Healthcare  -   Primary Health Care

1. Introduction

Arterial hypertension is a significant worldwide public health issue that affects over one-third of adults and is increasing in prevalence, especially in low and middle-income countries [1]. From 1990 to 2019, hypertension prevalence has increased twofold rising from 650 million to 1.3 billion individuals [1]. Defined as having a blood pressure of 140/90 mmHg or higher, this widespread condition can result in stroke, heart attack, heart failure, kidney damage, and various other health complications [1,2]. Moreover, there are multiple risk factors associated with arterial hypertension, including aging, lifestyle modifications, and obesity [2]. Conversely, individuals with arterial hypertension often face the challenge of not having a complete understanding of their condition. This is due to factors such as insufficient knowledge, the presence of other medical conditions, concerns about side effects, non-pharmacological treatment, and making lifestyle changes [3,4,5].
In light of the critical importance of knowledge in the management of hypertension, studies have shown that providing patients with education and empowerment results in improved adherence to medication, and thus more favorable treatment outcomes [6,7,8,9,10]. Adherence refers to the degree to which an individual’s actions align with the prescribed recommendations from a healthcare professional, encompassing medication usage, dietary adherence, and lifestyle modifications [11,12]. Lack of proper adherence to medication for hypertension has various significant effects on its management [13]. It increases the risk for cardiovascular events, poor renal outcomes (such as end-stage kidney disease), and even mortality [13,14]. Furthermore, studies have shown that better adherence to medication leads to a substantial reduction in cardiovascular risks and events [13,14]. Therefore, it is crucial for patients have high levels of medication adherence. However, that is not always the case, since there are multiple factors that affect medication adherence including social and economic circumstances, self-confidence, doctor-patient relationships, psychological aspects, complications related to hypertension, and various individual and social determinants [15,16,17,18,19,20].
Europe exhibits pronounced regional disparities for hypertension with studies even suggesting a greater frequency and elevated mortality rates associated with stroke compared to North America [21]. For example, the EMENO National Epidemiological Study from Greece has revealed that a significant prevalence of hypertension, specifically 39.6%, particularly among men and the elderly [22]. The current state of knowledge regarding the management of hypertension in Greece and the regional disparity in Europe necessitates the immediate development of a more comprehensive and robust information base. This is important since implementation of such approach could contribute to the improvement of the overall health outcomes and quality of life for patients with hypertension in Greece. Therefore,
The objective of this study was to investigate the levels of knowledge and adherence among patients with hypertension and to determine their correlation with the patients' sociodemographic and clinical characteristics. Additionally, the study aimed to explore the relationship between patients' knowledge and their medication adherence. This study was initiated to enhance the current information base on this subject and build a strong basis for future treatments and initiatives aimed at addressing any potential gaps in knowledge and adherence levels among individuals with hypertension.

2. Material and Methods

2.1. Study Design and Participants

A cross-sectional study was conducted among hypertensive patients who attended the cardiology outpatients’ clinics of two general hospitals in Greece, one military hospital in Athens, and one tertiary university hospital in Heraklion, Crete Island. Sociodemographic and clinical patients’ characteristics were the independent variables of the present study, whereas hypertension knowledge and pharmaceutical treatment adherence were the dependent variables. Additionally, hypertension knowledge levels operated as an independent variable when its association with treatment adherence was examined.
The inclusion criteria of the study were the following: a) age ≥ 18 years old; b) patients with diagnosed hypertension for at least six months; c) patients receiving prescribed antihypertensive medications; and d) sufficient knowledge of the Greek language. Patients who did not meet the above-predefined criteria, those who inadequately completed the provided questionnaires, and those who did not consent to participate in the study were excluded. On the strength of the above-mentioned criteria, 188 patients comprised the final study sample.

2.2. Methods and Instruments

Data collection was carried out in June 2023. To assess patients' knowledge of hypertension, the Greek version of the "Hypertension Knowledge Level Scale" (HK-LS) was used. Permission to use the questionnaire was obtained from its creators. The initial HK-LS, developed by Ekroc et al. (2012) and translated into Greek by Chatziefstratiou et al. (2015), consists of 22 statements [23,24]. Patients, completing the questionnaire, indicate whether each statement is correct, incorrect, or unknown. The statements cover six categories: disease definition (statements 1, 2), medication adherence (statements 3,4,5, and 12), medication (statements 6 to 9), lifestyle and habits (statements 10, 11, 13, 16, and 17), diet (statements 14, 15), and complications (statements 18 to 22). Only correct answers are scored, with a range of 0–22. Higher scores indicate sufficient knowledge, whereas lower scores indicate a knowledge deficit. The Cronbach’s alpha coefficient for the entire questionnaire was calculated at 0.67.
Furthermore, the Greek version of the "A-14 scale" [25] was used to assess patients' adherence to medication. Also, permission to use the questionnaire was obtained from its creators. This instrument consists of 14 questions, and responses are given on a Likert scale with five levels, ranging from "never" (0) to "very often" (4) [26]. The total score ranges from 0 to 56. Patients with scores between 50 and 56 are considered 90% adherent, while those with lower scores are classified as non-adherent. The questions explore the following four areas of compliance: a) patients' ability to remember to take their medications (question 13); b) patients' adaptation to medication for safety and effectiveness reasons (questions 1-4, 6, and 7); c) patients' lifestyle, including financial burden and duration of treatment (questions 5, 8-10, and 14); and d) patients' attitude towards their medication (questions 11 and 12). The Cronbach’s alpha coefficient for the entire instrument was 0.88.
Last but not least, the authors created a special questionnaire to gather data on the socio-demographic and clinical characteristics of the study participants.

2.3. Statistical Analysis

We performed the statistical analysis using SPSS version 26.0 (SPSS Inc., Chicago, IL, USA). Continuous variables were expressed as mean ± standard deviation and categorical variables were expressed as numbers and percentages. To correlate two continuous variables, we used the Pearson coefficient. Multiple linear regression analysis was used to examine the adjusted associations between independent variables and the scales HΚ-LS and A-14.

3. Results

The main socio-demographic and disease-related characteristics are depicted in Table 1. Most of the participants were male subjects (52.1%), without university education (78.2%), living with partners (83.5%), in urban locations (77.1%), having an active vocational status (94.7%), family history of cardiovascular disease (62.8%) and non-active smokers (67%).
Additionally, the mean [±Standard Deviation (SD)] participants’ age was 68.6 (±10.7) years old (Table 2). Also, the sample’s mean (±SD) monthly income, years living with the disease, and number of prescribed medications were 859.7 (±362.3) €, 9,7 (±8.5), and 1.6 (±1.3), respectively, as shown in Table 2. As can be seen in Table 2 the mean (±SD) scores of HK-LS and A-14 were 18.5 (±2.2) and 11.1 (±5.7), respectively. Moreover, the Cronbach’s alpha coefficients for the entire HK-LS and A-14 questionnaires were calculated as 0.67 and 0.88, respectively.
The Linear Bivariate Correlation between the scores of the HK-LS questionnaire and the A-14 questionnaire recorded a statistically strong positive relationship [r(188) = 0.885, p < 0.001], as underscored in Table 3.
By using multivariate analysis, it was found that the main independent parameters of higher knowledge of hypertension were age (p = 0.018), place of residence (p = 0.041), years with the disease (p = 0.012), and number of medications taken (p = 0.003). Specifically, higher age, residence in a more populous area, more years with the disease, and a lower number of medications correspond to a significantly higher level of knowledge, as indicated in Table 4.
Also, as demonstrated in Table 5, the main strong predictors of improved adherence to pharmacological therapy were increased age (p = 0.036), higher educational level (p = 0.048), more years with the disease (p = 0.001), and a lower number of medications taken (p = 0.003).

4. Discussion

The knowledge of patients with arterial hypertension regarding their condition plays a pivotal role in effectively managing this chronic illness and fostering self-care behaviors, including adherence to pharmacological therapy. Identifying the factors influencing patients' knowledge levels, alongside those directly impacting adherence to treatment plans, provides clinicians and administrators with insights into measures and policies tailored to individuals at high risk of low knowledge and adherence levels, thus addressing problematic self-care behaviors. Our study's findings reveal that hypertensive patients generally exhibit satisfactory knowledge levels about their condition and its management, whereas their adherence to prescribed pharmacological therapy remains notably low.
Our study underscores that patients with higher knowledge levels regarding their condition exhibit greater adherence to hypertension treatment. Additionally, factors such as advanced age, urban residence, longer disease duration, and fewer prescribed medications correlate strongly with elevated knowledge levels among patients with hypertension. Conversely, younger age, lower educational attainment, shorter disease duration, and a higher number of prescribed medications are associated with lower adherence levels. All patients were categorized as entirely non-adherent, as indicated by a maximum A-15 score of only 36. It is worth mentioning that the scale used for scoring ranged from 0 to 56, with scores between 50 and 56 representing 90% adherence.
As previously said, the participants in our study demonstrated sufficient levels of knowledge, as indicated by the mean score of 18.5±2.2 on the HK-LS scale, which has a range of 0-22. Higher scores on this scale indicate a higher degree of knowledge. Variability in patients' knowledge about hypertension is evident across different studies. For instance, one study revealed inadequate knowledge among over half of the participants [27], while another reported that 60% of patients possessed good knowledge [28]. Similarly, adherence levels vary, with one study finding that over half of hypertensive patients were not fully adherent [29], and another indicating medium-low adherence among 80% of participants taking multiple antihypertensive drugs [30]. Moreover, research on true resistant arterial hypertension revealed that 25% of patients did not adhere to prescribed medications [31]. Notably, better medication adherence has been associated with improved behavioral activation [32], while another study found high medication adherence rates among 63% of respondents [33]. These findings underscore the importance of addressing medication adherence in hypertension management and highlight the need for further research into associated factors.
Another significant finding of our study was the direct association between hypertension knowledge and adherence to medication which underscores the importance of empowering patients with adequate knowledge for effective long-term disease management and self-care. In line with our results, enhancing patients' knowledge of their condition is pivotal in promoting medication adherence, a finding supported by numerous studies [6,34,35,36].
Factors such as patients' age, disease duration, and medication regimen significantly influence knowledge levels and adherence to pharmacological therapy. Older patients with longer disease duration and fewer prescribed medications exhibit superior disease knowledge and treatment adherence, aligning with previous research indicating higher knowledge scores among older individuals [37]. In addition, studies [38,39] have found that older age is linked to higher levels of medication adherence in hypertensive patients. This improved adherence may lead to better blood pressure management and a reduced risk of complications like end-stage renal disease, as shown by [40]. Meanwhile, [41] revealed that younger patients exhibit diminished levels of adherence. However, contradictory findings exist, such as this study [42] suggesting that older age is a risk factor for poor medication adherence, emphasizing the need to consider age-related factors in adherence strategies.
Our study also reveals a significant association between higher knowledge levels and urban residence, echoing previous observations of knowledge disparities between urban and rural populations. Limited access to healthcare and educational resources in rural areas may contribute to lower hypertension knowledge levels, impacting self-care practices and medication adherence [43]. Efforts to bridge this gap should prioritize continuous health education, particularly in rural communities, where access to healthcare and educational resources may be limited [44]. Moreover, educational attainment influences medication adherence, with higher levels of education linked to better adherence to treatment regimens [45,46]. A higher level of education facilitates better disease understanding, a prerequisite for effective disease management and adherence to both pharmacological and non-pharmacological treatments. Interestingly, [30] study found higher adherence rates among patients without complete secondary education, contrary to our findings, suggesting the need for further exploration.

4.1. Limitations

Despite its merits, our study has a few limitations related to its design. Firstly, we used a cross-sectional research approach, which means we couldn’t establish causal relationships between knowledge, sociodemographic characteristics, and medication adherence. However, cross-sectional studies do provide valuable insights into the relationships between different variables and can help in designing future prospective/longitudinal studies. Therefore, future research could consider employing a longitudinal approach that includes additional measures like mortality rates and overall quality of life. Secondly, the findings of our study cannot be generalized due to the limited sample size. Since, we only included patients with hypertension from two tertiary hospitals in Greece. Finally, in terms of reliability, it is worth noting that while the Cronbach’s alpha coefficient for the Health Knowledge Literacy Scale (HK-LS) showed commendable internal consistency, the same measure for the A-14 tool, although considered acceptable [47], may be open to interpretation and potentially questionable. As a result, caution is advised when interpreting adherence findings due to concerns about reliability. However, the low medication adherence rates we observed highlight the importance of addressing this issue in patient care. Future research could focus on refining measurement tools or exploring alternative methods to enhance adherence assessments in patients with arterial hypertension.

5. Conclusions

In conclusion, this study suggests patient knowledge as a significant factor in effectively managing arterial hypertension and fostering adherence to pharmacological therapy. The findings further underscore the importance of empowering patients with a comprehensive understanding to facilitate long-term disease management and self-care practices. Factors such as age, urban residence, disease duration, and medication regimen significantly influence both knowledge levels and adherence behaviors, emphasizing the need for tailored interventions to address diverse patient demographics. It is important to note that older patients who have had the disease for a longer time and take fewer prescribed medications tend to have greater knowledge and adherence, which emphasizes the complex nature of managing hypertension.
Consequently, healthcare providers could play a pivotal role in implementing continuous health education initiatives, especially in rural areas, to bridge knowledge gaps and enhance medication adherence among hypertensive populations. By addressing knowledge gaps and adherence barriers, healthcare providers can significantly contribute to improving hypertension management outcomes and reducing associated complications. Finally, the study's limitations suggest further research into effective educational interventions and new adherence assessment tools that could enhance patient care.

Author Contributions

Conceptualization, K.G., E.P., H.B., M.B., N.V.F., P.I., A.C., A.A.C., A.P.; methodology, K.G., E.P., H.B., M.B., N.V.F., P.I., A.C., A.A.C., A.P; formal analysis, K.G., E.P., H.B., M.B., N.V.F., P.I.; validation, K.G., H.B., M.B., N.V.F., P.I., A.C.; investigation, K.G., E.P., H.B., M.B., N.V.F., P.I., A.C., A.A.C., A.P.; resources, K.G., E.P., H.B., M.B., N.V.F., P.I., A.C., & A.A.C.; writing— original draft preparation, K.G., E.P., & A.P.; writing—review and editing, K.G., E.P., H.B., M.B., N.V.F., P.I., A.C., A.A.C., A.P.; supervision, K.G., E.P., & A.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The ethics committees of both the military (3/6/21.03.2023) and the university (20645/11.05.2023 and 21487/17.05.2023) hospitals granted written permission. The collected data were used solely for this study, and all research stages followed the ethical standards of the Helsinki Declaration of 1975, revised in 2013.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Acknowledgments

The authors would like to thank all participants for their voluntary participation.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. World Health Organization. First WHO report details devastating impact of hypertension and ways to stop it. Available online: https://www.who.int/news/item/19-09-2023-first-who-report-details-devastating-impact-of-hypertension-and-ways-to-stop-it#:~:text=The%20report%20shows%20approximately%204,1%20in%203%20adults%20worldwide. (accessed on 17 March 2024).
  2. Williams, B.; Mancia, G.; Spiering, W.; Agabiti Rosei, E.; Azizi, M.; Burnier, M.; Clement, D.L.; Coca, A.; de Simone, G.; Dominiczak, A.; et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018, 39, 3021–3104. [Google Scholar] [CrossRef]
  3. Kisokanth, G.; Ilankoon, I.; Arulanandem, K.; Goonewardena, C.S.E.; Sundaresan, K.T.; Joseph, J. Assessment of Knowledge on Hypertension, its consequences and management practices among hypertensive patients - A descriptive study. Journal of the Postgraduate Institute of Medicine 2016. [Google Scholar] [CrossRef]
  4. Martsevich, S.Y.; Semenova, Y.V.; Kutishenko, N.P.; Zagrebelnyy, А.V.; Ginzburg, М.L. Awareness of cardiovascular disease, its risk factors, and its association with attendance at outpatient clinics in acute coronary syndrome patients. Integrative Medicine Research 2017, 6, 240–244. [Google Scholar] [CrossRef]
  5. Iancu, M.A.; Mateiciuc, I.-I.; Stanescu, A.-M.A.; Matei, D.; Diaconu, C.C. Therapeutic Compliance of Patients with Arterial Hypertension in Primary Care. Medicina 2020, 56, 631. [Google Scholar] [CrossRef]
  6. Paczkowska, A.; Hoffmann, K.; Kus, K.; Kopciuch, D.; Zaprutko, T.; Ratajczak, P.; Michalak, M.; Nowakowska, E.; Bryl, W. Impact of patient knowledge on hypertension treatment adherence and efficacy: A single-centre study in Poland. International Journal of Medical Sciences 2021, 18, 852–860. [Google Scholar] [CrossRef]
  7. Lopes Oliveira, T.; de Paula Miranda, L.; de Sousa Fernandes, P.; Prates Caldeira, A. Eficácia da educação em saúde no tratamento não medicamentoso da hipertensão arterial. Acta Paulista de Enfermagem 2013, 26, 179–184. [Google Scholar] [CrossRef]
  8. Náfrádi, L.; Nakamoto, K.; Schulz, P.J. Is patient empowerment the key to promote adherence? A systematic review of the relationship between self-efficacy, health locus of control and medication adherence. PLOS ONE 2017, 12, e0186458. [Google Scholar] [CrossRef]
  9. Shen, Z.; Shi, S.; Ding, S.; Zhong, Z. Mediating Effect of Self-Efficacy on the Relationship Between Medication Literacy and Medication Adherence Among Patients With Hypertension. Frontiers in Pharmacology 2020, 11. [Google Scholar] [CrossRef]
  10. Algabbani, F.M.; Algabbani, A.M. Treatment adherence among patients with hypertension: findings from a cross-sectional study. Clinical Hypertension 2020, 26, 18. [Google Scholar] [CrossRef]
  11. Burkhart, P.V.; Sabaté, E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh 2003, 35, 207. [Google Scholar] [CrossRef]
  12. Hamrahian, S.M.; Maarouf, O.H.; Fülöp, T. A Critical Review of Medication Adherence in Hypertension: Barriers and Facilitators Clinicians Should Consider. Patient Prefer Adherence 2022, 16, 2749–2757. [Google Scholar] [CrossRef]
  13. Hamdidouche, I.; Jullien, V.; Boutouyrie, P.; Billaud, E.; Azizi, M.; Laurent, S. Drug adherence in hypertension: from methodological issues to cardiovascular outcomes. J Hypertens 2017, 35, 1133–1144. [Google Scholar] [CrossRef]
  14. Corrao, G.; Parodi, A.; Nicotra, F.; Zambon, A.; Merlino, L.; Cesana, G.; Mancia, G. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens 2011, 29, 610–618. [Google Scholar] [CrossRef]
  15. Nielsen, J.Ø.; Shrestha, A.D.; Neupane, D.; Kallestrup, P. Non-adherence to anti-hypertensive medication in low- and middle-income countries: a systematic review and meta-analysis of 92443 subjects. Journal of Human Hypertension 2017, 31, 14–21. [Google Scholar] [CrossRef]
  16. Lewis, L.M.; Ogedegbe, C.; Ogedegbe, G. Enhancing adherence of antihypertensive regimens in hypertensive African–Americans: current and future prospects. Expert Review of Cardiovascular Therapy 2012, 10, 1375–1380. [Google Scholar] [CrossRef]
  17. Mamaghani, E.A.; Hasanpoor, E.; Maghsoodi, E.; Soleimani, F. Barriers to Medication Adherence among Hypertensive Patients in Deprived Rural Areas. Ethiop J Health Sci 2020, 30, 85–94. [Google Scholar] [CrossRef] [PubMed]
  18. Najjuma, J.N.; Brennaman, L.; Nabirye, R.C.; Ssedyabane, F.; Maling, S.; Bajunirwe, F.; Muhindo, R. Adherence to Antihypertensive Medication: An Interview Analysis of Southwest Ugandan Patients’ Perspectives. Annals of Global Health 2020. [Google Scholar] [CrossRef] [PubMed]
  19. Sari, D.N.; Utami, W.; Zairina, E. The Influence of Feeling Lonely and Received Social Support on Medication Adherence in Elderly with Hypertension. JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA 2022. [Google Scholar]
  20. Shuper, V.; Shuper, S.; Rykova Yu, O.; Trefanenko, I.; Shumko, H. Estimation of the Compliance Level of Middle Age Patients with Arterial Hypertension. Зміст Contents, 192.
  21. Wafa, H.A.; Wolfe, C.D.A.; Emmett, E.; Roth, G.A.; Johnson, C.O.; Wang, Y. Burden of Stroke in Europe: Thirty-Year Projections of Incidence, Prevalence, Deaths, and Disability-Adjusted Life Years. Stroke 2020, 51, 2418–2427. [Google Scholar] [CrossRef] [PubMed]
  22. Stergiou, G.S.; Menti, A.; Kalpourtzi, N.; Gavana, M.; Vantarakis, A.; Chlouverakis, G.; Hajichristodoulou, C.; Trypsianis, G.; Voulgari, P.V.; Alamanos, Y.; et al. Prevalence, awareness, treatment and control of hypertension in Greece: EMENO national epidemiological study. Journal of Hypertension 2021, 39, 1034–1039. [Google Scholar] [CrossRef] [PubMed]
  23. Erkoc, S.B.; Isikli, B.; Metintas, S.; Kalyoncu, C. Hypertension Knowledge-Level Scale (HK-LS): a study on development, validity and reliability. International journal of environmental research and public health 2012, 9, 1018–1029. [Google Scholar] [CrossRef]
  24. Chatziefstratiou, A.A.; Giakoumidakis, K.; Fotos, N.V.; Baltopoulos, G.; Brokalaki-Pananoudaki, H. Translation and validation of the Greek version of the hypertension knowledge-level scale. Journal of clinical nursing 2015, 24, 3417–3424. [Google Scholar] [CrossRef]
  25. Chatziefstratiou, A.; Giakoumidakis, K.; Fotos, N.V.; Baltopoulos, G.; Brokalaki, H. Scales for assessing medication adherence in patients with hypertension. Br J Nurs 2019, 28, 1388–1392. [Google Scholar] [CrossRef]
  26. Jank, S.; Bertsche, T.; Schellberg, D.; Herzog, W.; Haefeli, W.E. The A14-scale: development and evaluation of a questionnaire for assessment of adherence and individual barriers. Pharm World Sci 2009, 31, 426–431. [Google Scholar] [CrossRef]
  27. Sobierajski, T.; Surma, S.; Romańczyk, M.; Banach, M.; Oparil, S. Knowledge of Primary Care Patients Living in the Urban Areas about Risk Factors of Arterial Hypertension. International Journal of Environmental Research and Public Health 2023, 20, 1250. [Google Scholar] [CrossRef]
  28. Rai, L.; Gautam, R. Knowledge and Treatment Complience among Hypertensive Patient Attending in a Tertiary Level Hospital, Kathmandu. Tribhuvan University Journal 2023. [Google Scholar] [CrossRef]
  29. Radic, J.; Dogas, H.; Vuckovic, M.; Kolak, E.; Gelemanovic, A.; Nenadic, D.B.; Radic, M. MEDICATION ADHERENCE AND GENDER DIFFERENCE IN HYPERTENSIVE PATIENTS. Journal of Hypertension 2023, 41, e314. [Google Scholar] [CrossRef]
  30. Campos, K.J.; Almeida, E.E.A.; Leão, J.A.F.; Soares, A.K.V.L.; Cordeiro, R.D.; Amorim, W.R.d.; Soares, P.V.L.; Brito, C.C.; Oliveira, M. Factors associated with adherence to pharmacological treatment by hypertensive patients: Fatores associados à adesão ao tratamento farmacológico por pacientes hipertensos. Concilium 2023, 23, 291–302. [Google Scholar] [CrossRef]
  31. Rekovets, O.L.; Sirenko, Y.M. Adherence to treatment in patients with resistant arterial hypertension. Ukrainian Journal of Cardiology 2023. [Google Scholar]
  32. Fragoulis, C.; Prentakis, A.G.; Kontogianni, E.; Polyzos, D.; Tsioufis, P.A.; Fragouli, D.; Leontsinis, I.; Mantzouranis, E.; Sakalidis, A.; Mavroudis, A.; et al. Medication adherence in relation with physical activity in hypertensive patients : data from a behavioral cardiology unit. European Journal of Preventive Cardiology 2023, 30. [Google Scholar] [CrossRef]
  33. Mahdi, H.A.; Al-Humairi, A.K. Assessment of knowledge about hypertension among hypertensive patients in Babylon Province. Medical Journal of Babylon 2022, 19, 31–36. [Google Scholar] [CrossRef]
  34. Jankowska-Polańska, B.; Uchmanowicz, I.; Dudek, K.; Mazur, G. Relationship between patients' knowledge and medication adherence among patients with hypertension. Patient Prefer Adherence 2016, 10, 2437–2447. [Google Scholar] [CrossRef] [PubMed]
  35. Ernawati, I.; Lubada, E.I.; Lusiyani, R.; Prasetya, R.A. Association of adherence measured by self-reported pill count with achieved blood pressure level in hypertension patients: a cross-sectional study. Clinical Hypertension 2022, 28, 12. [Google Scholar] [CrossRef] [PubMed]
  36. Rahmawati, R.; Bajorek, B. Factors affecting self-reported medication adherence and hypertension knowledge: A cross-sectional study in rural villages, Yogyakarta Province, Indonesia. Chronic Illness 2018, 14, 212–227. [Google Scholar] [CrossRef]
  37. Sadeq, R.; Lafta, R.K. Knowledge, attitude and practice about hypertension in hypertensive patients attending hospitals in Baghdad, Iraq. South East Asia Journal of Public Health 2017, 7, 29–34. [Google Scholar] [CrossRef]
  38. Uchmanowicz, B.; Jankowska, E.A.; Uchmanowicz, I.; Morisky, D.E. Self-Reported Medication Adherence Measured With Morisky Medication Adherence Scales and Its Determinants in Hypertensive Patients Aged ≥60 Years: A Systematic Review and Meta-Analysis. Front Pharmacol 2019, 10, 168. [Google Scholar] [CrossRef]
  39. Fallatah, M.S.; Alghamdi, G.S.; Alzahrani, A.A.; Sadagah, M.M.; Alkharji, T.M. Insights Into Medication Adherence Among Patients With Chronic Diseases in Jeddah, Saudi Arabia: A Cross-Sectional Study. Cureus 2023, 15, e37592. [Google Scholar] [CrossRef]
  40. Roy, L.; White-Guay, B.; Dorais, M.; Dragomir, A.; Lessard, M.; Perreault, S. Adherence to antihypertensive agents improves risk reduction of end-stage renal disease. Kidney International 2013, 84, 570–577. [Google Scholar] [CrossRef]
  41. Ghelman, L.G.; Assunção, M.F.d.; Farias, S.N.P.d.; Araujo, E.F.d.S.; Souza, M.H.d.N. Adesão ao tratamento medicamentoso da hipertensão arterial e fatores associados. Rev. enferm. UFPE on line 2018, 1273–1280. [Google Scholar] [CrossRef]
  42. Wakai, E.; Ikemura, K.; Kato, C.; Okuda, M. Effect of number of medications and complexity of regimens on medication adherence and blood pressure management in hospitalized patients with hypertension. PLOS ONE 2021, 16, e0252944. [Google Scholar] [CrossRef]
  43. Wolde, M.; Azale, T.; Debalkie Demissie, G.; Addis, B. Knowledge about hypertension and associated factors among patients with hypertension in public health facilities of Gondar city, Northwest Ethiopia: Ordinal logistic regression analysis. PLOS ONE 2022, 17, e0270030. [Google Scholar] [CrossRef]
  44. Gusty, R.; Effendi, N.; Abdullah, K.L.; Syafrita, Y. Association between Knowledge and Self-care Adherence among Elderly Hypertensive Patient in Dwelling Community. Open Access Macedonian Journal of Medical Sciences 2022, 10, 206–212. [Google Scholar] [CrossRef]
  45. Guo, A.; Jin, H.; Mao, J.; Zhu, W.; Zhou, Y.; Ge, X.; Yu, D. Impact of health literacy and social support on medication adherence in patients with hypertension: a cross-sectional community-based study. BMC Cardiovascular Disorders 2023, 23, 93. [Google Scholar] [CrossRef]
  46. Pristianty, L.; Hingis, E.S.; Priyandani, Y.; Rahem, A. Relationship between knowledge and adherence to hypertension treatment. J Public Health Afr 2023, 14, 2502. [Google Scholar] [CrossRef]
  47. Tavakol, M.; Dennick, R. Making sense of Cronbach's alpha. Int J Med Educ 2011, 2, 53–55. [Google Scholar] [CrossRef]
Table 1. Socio-demographic and disease-related characteristics.
Table 1. Socio-demographic and disease-related characteristics.
Ν N %
Gender Men 98 52.1%
Women 90 47.9%
Educational level Up to Post-secondary education 147 78.2%
Higher Education/ Holder MSc or PhD 41 21.8%
Type of living Alone 31 16.5%
Living with others 157 83.5%
Place of residence Civil centre 145 77.1%
Countryside 43 22.9%
Working status Worker 178 94.7%
Unemployed 10 5.3%
Family history of cardiovascular disease Yes 118 62.8%
No 70 37.2%
Smoking Smoker 62 33.0%
Non or former smoker 126 67.0%
Table 2. Other characteristics.
Table 2. Other characteristics.
Mean Standard Deviation
Age (years) 68.6 10.7
Monthly income (euro) 859.7 362.3
Years with the disease 9.7 8.5
Number of medicines 1.6 1.3
HΚ-LS Score 18.5 2.2
A-14 Score 11.1 5.7
Table 3. Linear Bivariate Correlation between the total scores of HK-LS and A-14 questionnaires.
Table 3. Linear Bivariate Correlation between the total scores of HK-LS and A-14 questionnaires.
HΚ-LS Score A-14 Score
HΚ-LS Score Pearson Correlation 1 0.885**
Sig. (2-tailed) 0.000
N 188 188
A-14 Score Pearson Correlation 0.885** 1
Sig. (2-tailed) 0.000
N 188 188
** Correlation is significant at the 0.01 level (2-tailed).
Table 4. Multivariate analysis between the demographic characteristics and HΚ-LS Score of the participants.
Table 4. Multivariate analysis between the demographic characteristics and HΚ-LS Score of the participants.
Model Unstandardized Coefficients Standardized Coefficients t Sig. 95.0% Confidence Interval for B
B Std. Error Beta Lower Bound Upper Bound
1 (Constant) 16.991 2.040 8.329 0.000 12.965 21.017
Gender -0.411 0.343 -0.095 -1.199 0.232 -1.089 0.266
Educational level 0.676 0.403 0.130 1.677 0.095 -0.120 1.472
Type of living 0.140 0.455 0.024 0.308 0.758 -0.758 1.039
Place of residence -0.789 0.384 -0.154 -2.058 0.041 -1.546 -0.032
Working status 0.466 0.694 0.049 0.672 0.502 -0.903 1.835
Family history of cardiovascular disease -0.261 0.327 -0.059 -0.800 0.425 -0.906 0.383
Smoking -0.502 0.355 -0.109 -1.412 0.160 -1.203 0.200
Age 0.039 0.016 0.193 2.379 0.018 0.007 0.071
Monthly income 0.000 0.000 0.025 0.333 0.740 -0.001 0.001
Years with disease 0.052 0.020 0.202 2.549 0.012 0.012 0.092
Number of medicines -0.385 0.128 -0.224 -3.014 0.003 -0.636 -0.133
a. Dependent Variable: HΚ-LS Score.
Table 5. Multivariate analysis between the demographic characteristics and A-14 Score of the participants.
Table 5. Multivariate analysis between the demographic characteristics and A-14 Score of the participants.
Model Unstandardized Coefficients Standardized Coefficients t Sig. 95.0% Confidence Interval for B
B Std. Error Beta Lower Bound Upper Bound
1 (Constant) 6.060 5.316 1.140 0.256 -4.431 16.550
Gender -0.852 0.894 -0.075 -0.953 0.342 -2.617 0.913
Educational level 2.089 1.051 0.152 1.987 0.048 0.015 4.164
Type of living -0.247 1.187 -0.016 -0.208 0.835 -2.589 2.095
Place of residence -0.311 1.000 -0.023 -0.311 0.756 -2.283 1.662
Working status 1.421 1.808 0.056 0.786 0.433 -2.146 4.989
Family history of cardiovascular disease -1.234 0.851 -0.105 -1.450 0.149 -2.913 0.446
Smoking -1.496 0.926 -0.124 -1.615 0.108 -3.323 0.332
Age 0.090 0.043 0.170 2.110 0.036 0.006 0.174
Monthly income 0.001 0.001 0.070 0.935 0.351 -0.001 0.003
Years with diesease 0.181 0.053 0.269 3.421 0.001 0.076 0.285
Number of medicines -1.014 0.333 -0.224 -3.049 0.003 -1.670 -0.358
a. Dependent Variable: A-14 Score
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
bsky
MDPI Initiatives
Important Links
Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated